P-D 007 Pill - yellow three-sided, 12mm
Generic Name: phenytoin
Pill with imprint P-D 007 is Yellow, Three-sided and has been identified as Dilantin Infatabs 50 mg. It is supplied by Pfizer U.S. Pharmaceuticals Group.
Dilantin is used in the treatment of Seizures; Epilepsy; Neurosurgery; Status Epilepticus; Seizure Prophylaxis During or Following Neurosurgery and belongs to the drug classes group I antiarrhythmics, hydantoin anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Dilantin 50 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for P-D 007
Dilantin Infatabs
- Generic Name
- phenytoin
- Imprint
- P-D 007
- Strength
- 50 mg
- Color
- Yellow
- Size
- 12.00 mm
- Shape
- Three-sided
- Availability
- Prescription only
- Drug Class
- Group I antiarrhythmics, Hydantoin anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer U.S. Pharmaceuticals Group
- Inactive Ingredients
-
D&C Yellow No. 10,
FD&C Yellow No. 6,
aluminum oxide,
saccharin sodium,
magnesium silicate,
sucrose,
magnesium stearate,
water
Note: Inactive ingredients may vary.
Labelers / Repackagers
NDC Code | Labeler / Repackager |
---|---|
00071-0007 | Pfizer Inc. |
59762-5210 | Viatris |
Related images for "P-D 007"
More about Dilantin (phenytoin)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (77)
- Drug images
- Latest FDA alerts (3)
- Side effects
- Dosage information
- During pregnancy
- Generic availability
- Drug class: group I antiarrhythmics
- Breastfeeding
Patient resources
- Dilantin drug information
- Dilantin injection
- Dilantin Infatabs (Advanced Reading)
- Dilantin-125 (Advanced Reading)
- Dilantin Infatabs
- Dilantin Kapseals
Other brands
Phenytek, Phenytoin Sodium, Prompt
Professional resources
- Dilantin prescribing information
- Dilantin Infatabs (FDA)
- Dilantin-125 (FDA)
- Phenytoin (AHFS Monograph)
Other brands
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.